Who invested in COMPASS Pathways

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$200Mraised across 1 round since 2026, from 1 source

Latest round: Round, $200MFeb 2026
Investors: 5

See who backed them

COMPASS PathwaysBiotechnology1 / 12Their pitch deckCOMPASS Pathways's pitch deck, 12 slidesEach slide read for what it argues, against the decks that raised at the same stage.

The rounds

Feb 2026
Round$200M
Source recorded

Founders and team

From COMPASS Pathways's own website: 7 on the team.

Kabir NathChief Executive Officer
Dr. Guy GoodwinChief Medical Officer
Dr. Michael GoldChief Research & Development Officer
Dr. Steve LevineChief Patient Officer
Kelley BoucherChief People Officer
Lori EnglebertChief Commercial Officer
Teri LoxamChief Financial Officer

Everyone who backed them

Founders FundVC firm1round

RA Capital ManagementPrivate equity1round

Perceptive AdvisorsAsset manager1round

Vivo CapitalPrivate equity1round

Catalio Capital ManagementVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list COMPASS Pathways as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.